Cortese Bernardo, Trani Carlo, Lorenzoni Roberto, Sbarzaglia Paolo, Latib Azeem, Tommasino Antonella, Bovenzi Francesco, Cremonesi Alberto, Burzotta Francesco, Pitì Antonino, Tarantino Fabio, Colombo Antonio
Interventional Cardiology, A.O. Fatebenefratelli Milano, Italy.
Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
Int J Cardiol. 2014 Aug 1;175(2):280-4. doi: 10.1016/j.ijcard.2014.05.012. Epub 2014 May 16.
Percutaneous angioplasty of lower limb disease is commonly performed with a transfemoral access. In the coronary field, a transradial approach has shown to reduce access-site bleeding and adverse clinical events. This route has not yet been well studied for the majority of peripheral interventions, like those involving the iliac arteries. In this study we sought to evaluate the feasibility and safety of this approach for iliac interventions.
Multicenter study was performed at high-volume centers with experience in transradial percutaneous interventions. Primary endpoint of the study was procedural success; secondary endpoints included in-hospital bleeding, 1-month freedom from adverse events and the rate of radial occlusion. Feasibility of this technique was evaluated by recording procedural and fluoroscopy time and contrast load.
A total of 149 patients from 5 centers were enrolled. The population had a medium risk profile, with 48% of patients having TASC 2 or 3 lesions. Procedural success was achieved in 98.7% of the population, and we did not register in-hospital complications, including both vascular access site and procedural-related complications. An ancillary transfemoral approach was used in 13% of patients. One-month freedom from symptoms was achieved in 97.3% of patients, and the rate of radial occlusion was 2.7%. Major determinants of an unsuccessful procedure were the use of normal 6 or 7-Fr introducer with guiding catheter, TASC D lesion attempt, lesion length>30 mm and total occlusion.
A transradial approach for iliac disease may be a feasible and safe alternative to the transfemoral route in experienced hands, in the light of significant technical improvements and dedicated devices.
下肢疾病的经皮血管成形术通常采用经股动脉入路。在冠状动脉领域,经桡动脉入路已显示可减少穿刺部位出血及不良临床事件。对于大多数外周介入治疗,如涉及髂动脉的介入治疗,此入路尚未得到充分研究。在本研究中,我们旨在评估经桡动脉入路用于髂动脉介入治疗的可行性和安全性。
在有经桡动脉经皮介入经验的高容量中心进行多中心研究。研究的主要终点是手术成功;次要终点包括住院期间出血、1个月无不良事件以及桡动脉闭塞率。通过记录手术时间、透视时间和造影剂用量来评估该技术的可行性。
来自5个中心的149例患者入组。该人群具有中等风险特征,48%的患者有TASC 2或3级病变。98.7%的患者手术成功,我们未记录到住院期间并发症,包括血管穿刺部位及与手术相关的并发症。13%的患者使用了辅助经股动脉入路。97.3%的患者1个月无症状,桡动脉闭塞率为2.7%。手术失败的主要决定因素是使用普通6或7F穿刺鞘及引导导管、尝试处理TASC D级病变、病变长度>30 mm和完全闭塞。
鉴于显著的技术改进和专用设备,在经验丰富的操作者手中,经桡动脉入路治疗髂动脉疾病可能是经股动脉入路可行且安全的替代方法。